Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders


All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Quarterly results
Appointed COO
Inv. presentation
ATOSSA THERAPEUTICS, INC. (ATOS) Create: Alert

All | News | Filings
Date FiledTypeDescription
05/05/2023 4 WEAVER GREGORY L (Director) has filed a Form 4 on ATOSSA THERAPEUTICS, INC.
Txns: Granted 125,000 options to buy @ $0.662, valued at $82.8k
05/05/2023 4 Remmel H. Lawrence (Director) has filed a Form 4 on ATOSSA THERAPEUTICS, INC.
Txns: Granted 125,000 options to buy @ $0.662, valued at $82.8k
05/05/2023 4 Steinhart Richard I (Director) has filed a Form 4 on ATOSSA THERAPEUTICS, INC.
Txns: Granted 125,000 options to buy @ $0.662, valued at $82.8k
05/05/2023 4 Chen Shu-Chih (Director) has filed a Form 4 on ATOSSA THERAPEUTICS, INC.
Txns: Granted 125,000 options to buy @ $0.662, valued at $82.8k
05/05/2023 4 Galli Stephen J (Director) has filed a Form 4 on ATOSSA THERAPEUTICS, INC.
Txns: Granted 125,000 options to buy @ $0.662, valued at $82.8k
03/06/2023 4 QUAY STEVEN C (President & CEO) has filed a Form 4 on ATOSSA THERAPEUTICS, INC.
Txns: Granted 1,873,100 options to buy @ $0.72, valued at $1.3M
03/06/2023 4 Guse Kyle (CFO, Gen Counsel and Secretary) has filed a Form 4 on ATOSSA THERAPEUTICS, INC.
Txns: Granted 557,900 options to buy @ $0.72, valued at $401.7k
05/16/2022 4 Chen Shu-Chih (Director) has filed a Form 4 on ATOSSA THERAPEUTICS, INC.
Txns: Granted 50,000 options to buy @ $0.93, valued at $46.5k
05/16/2022 4 Galli Stephen J (Director) has filed a Form 4 on ATOSSA THERAPEUTICS, INC.
Txns: Granted 50,000 options to buy @ $0.93, valued at $46.5k
05/16/2022 4 Remmel H. Lawrence (Director) has filed a Form 4 on ATOSSA THERAPEUTICS, INC.
Txns: Granted 50,000 options to buy @ $0.93, valued at $46.5k
05/16/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
05/16/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
02/28/2022 4 Guse Kyle (CFO, Gen Counsel and Secretary) has filed a Form 4 on ATOSSA THERAPEUTICS, INC.
Txns: Granted 746,667 options to buy @ $1.25, valued at $933.3k
02/28/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
07/07/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
05/18/2021 4 Galli Stephen J (Director) has filed a Form 4 on ATOSSA THERAPEUTICS, INC.
Txns: Granted 50,000 options to buy @ $2.9, valued at $145k
05/18/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
05/18/2021 4 Guse Kyle (CFO, Gen Counsel and Secretary) has filed a Form 4 on ATOSSA THERAPEUTICS, INC.
Txns: Granted 850,000 options to buy @ $2.9, valued at $2.5M
05/18/2021 4 Chen Shu-Chih (Director) has filed a Form 4 on ATOSSA THERAPEUTICS, INC.
Txns: Granted 50,000 options to buy @ $2.9, valued at $145k
05/18/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
05/18/2021 4 Remmel H. Lawrence (Director) has filed a Form 4 on ATOSSA THERAPEUTICS, INC.
Txns: Granted 50,000 options to buy @ $2.9, valued at $145k
05/18/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
05/18/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
05/19/2020 4 Remmel H. Lawrence (Director) has filed a Form 4 on ATOSSA THERAPEUTICS, INC.
Txns: Granted 45,000 options to buy @ $1.7, valued at $76.5k
05/19/2020 4 WEAVER GREGORY L (Director) has filed a Form 4 on ATOSSA THERAPEUTICS, INC.
Txns: Granted 70,000 options to buy @ $1.7, valued at $119k
05/19/2020 4 Steinhart Richard I (Director) has filed a Form 4 on ATOSSA THERAPEUTICS, INC.
Txns: Granted 45,000 options to buy @ $1.7, valued at $76.5k
05/19/2020 4 Chen Shu-Chih (Director) has filed a Form 4 on ATOSSA THERAPEUTICS, INC.
Txns: Granted 45,000 options to buy @ $1.7, valued at $76.5k
05/19/2020 4 Galli Stephen J (Director) has filed a Form 4 on ATOSSA THERAPEUTICS, INC.
Txns: Granted 45,000 options to buy @ $1.7, valued at $76.5k
04/13/2020 4 Guse Kyle (CFO, Gen Counsel and Secretary) has filed a Form 4 on ATOSSA THERAPEUTICS, INC.
Txns: Granted 195,000 options to buy @ $1.48, valued at $288.6k
Granted 395,000 options to buy @ $1.48, valued at $584.6k
04/13/2020 4 QUAY STEVEN C (President & CEO) has filed a Form 4 on ATOSSA THERAPEUTICS, INC.
Txns: Granted 195,000 options to buy @ $1.48, valued at $288.6k
Granted 1,305,000 options to buy @ $1.48, valued at $1.9M
05/21/2019 4 WEAVER GREGORY L (Director) has filed a Form 4 on ATOSSA GENETICS INC
Txns: Granted 45,000 options to buy @ $2.52, valued at $113.4k
05/21/2019 4 Steinhart Richard I (Director) has filed a Form 4 on ATOSSA GENETICS INC
Txns: Granted 45,000 options to buy @ $2.52, valued at $113.4k
05/21/2019 4 Galli Stephen J (Director) has filed a Form 4 on ATOSSA GENETICS INC
Txns: Granted 45,000 options to buy @ $2.52, valued at $113.4k
05/21/2019 4 Remmel H. Lawrence (Director) has filed a Form 4 on ATOSSA GENETICS INC
Txns: Granted 45,000 options to buy @ $2.52, valued at $113.4k
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy